Dr. Kevin M. O'connor, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Saint Giles Ct, Belmont, NC 28012 Phone: 704-825-0799 Fax: 704-825-0799 |
Dr. Andol Stephen Yeh, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4201 Belle Meade Cir, Belmont, NC 28012 Phone: 704-825-3694 |
Larry Skeete, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1223 Spruce St, Belmont, NC 28012 Phone: 980-834-8800 Fax: 980-834-9879 |
Dr. David N Ferrand, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 119 Dorie Dr, Belmont, NC 28012 Phone: 704-825-5474 |
News Archive
Experts have warned that some private clinics that are offering safe alternatives to mammograms as breast cancer screening are doing more harm than good. It is seen that clinics offering services like botox, liposuction and spray tans are increasingly providing breast cancer screening that uses thermal imaging and "electrical impedance" technology. These methods are being used on women as young as 20, with claims they can detect cancer years earlier than mammograms.
Today, Minister for Children, Equality, Disability, Integration and Youth, Roderic O'Gorman, TD, launched the COVISION research project to help children and their communities around the world adjust to the challenges of the Covid-19 pandemic and beyond.
David A. Solomon, who will graduate from Georgetown University School of Medicine this year with M.D. and Ph.D. degrees, has been designated one of four outstanding early-career scientists by the American Association for Cancer Research (AACR) - a highly prestigious honor. Solomon will present his work at a special symposium, Future Leaders in Basic Cancer Research, on April 2nd at the AACR Annual Meeting 2012 in Chicago.
State legislators in Michigan could vote as early as Tuesday on a bill to expand the health insurance program for the poor. In Wyoming, lawmakers consider an alternative approach developed by Arkansas. And in Arizona, a group trying to block the expansion faces a deadline to put the matter on the ballot.
A blood sample could one day be enough to diagnose many types of solid cancers, or to monitor the amount of cancer in a patient's body and responses to treatment. Previous versions of the approach, which relies on monitoring levels of tumor DNA circulating in the blood, have required cumbersome and time-consuming steps to customize it to each patient or have not been sufficiently sensitive.
› Verified 8 days ago